You can:
Name | Delta-type opioid receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | OPRD1 |
Synonym | D-OR-1 DOR opioid receptor OP1 DOP [ Show all ] |
Disease | Cough Overactive bladder disorder Bladder disease Moderate-to-severe pain Diarrhea-predominant IBS [ Show all ] |
Length | 372 |
Amino acid sequence | MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA |
UniProt | P41143 |
Protein Data Bank | 4rwd, 4rwa, 4n6h |
GPCR-HGmod model | P41143 |
3D structure model | This structure is from PDB ID 4rwd. |
BioLiP | BL0303696,BL0303697, BL0265712, BL0265705,BL0265706,BL0265707,, BL0303699,BL0303701, BL0303698,BL0303700 |
Therapeutic Target Database | T58992 |
ChEMBL | CHEMBL236 |
IUPHAR | 317 |
DrugBank | BE0000420 |
Name | Biphalin |
---|---|
Molecular formula | C46H56N10O10 |
IUPAC name | (2S)-2-amino-N-[(2R)-1-[[2-[[(2S)-1-[2-[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide |
Molecular weight | 909.014 |
Hydrogen bond acceptor | 12 |
Hydrogen bond donor | 12 |
XlogP | 1.4 |
Synonyms | (Tyr-ala-gly-phe-NH2)2 Bis(tyrosyl-alanyl-glycyl-phenylalaninamide)hydrazide enkephalin dimer 83916-01-2 D-ENK [ Show all ] |
Inchi Key | DESSEGDLRYOPTJ-VRANXALZSA-N |
Inchi ID | InChI=1S/C46H56N10O10/c1-27(51-43(63)35(47)21-31-13-17-33(57)18-14-31)41(61)49-25-39(59)53-37(23-29-9-5-3-6-10-29)45(65)55-56-46(66)38(24-30-11-7-4-8-12-30)54-40(60)26-50-42(62)28(2)52-44(64)36(48)22-32-15-19-34(58)20-16-32/h3-20,27-28,35-38,57-58H,21-26,47-48H2,1-2H3,(H,49,61)(H,50,62)(H,51,63)(H,52,64)(H,53,59)(H,54,60)(H,55,65)(H,56,66)/t27-,28-,35+,36+,37+,38+/m1/s1 |
PubChem CID | 5487663 |
ChEMBL | CHEMBL200199 |
IUPHAR | N/A |
BindingDB | 21014 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 1.0 nM | PMID18821747 | BindingDB |
EC50 | 1.0 nM | PMID18821747 | ChEMBL |
EC50 | 1.1 nM | PMID18821747, PMID19762245, PMID17516639, PMID20617791, PMID20560643, PMID21366266, PMID16509592, PMID18266313, PMID17201419 | BindingDB,ChEMBL |
EC50 | 1.122 nM | PMID19762245, PMID17516639, PMID20617791, PMID20560643, PMID21366266, PMID16509592 | ChEMBL |
EC50 | 2.5 nM | PMID23623418 | ChEMBL |
EC50 | 2.6 nM | PMID18266313 | ChEMBL |
Emax | 27.0 % | PMID16275086, PMID23623418 | ChEMBL |
Emax | 83.0 % | PMID18821747, PMID19762245, PMID17516639, PMID20617791, PMID20560643, PMID21366266, PMID16509592, PMID18266313 | ChEMBL |
Emax | 84.0 % | PMID17201419 | ChEMBL |
IC50 | 1.1 nM | PMID17201419 | BindingDB |
IC50 | 1.122 nM | PMID17201419 | ChEMBL |
IC50 | 2.5 nM | PMID16275086 | BindingDB,ChEMBL |
IC50 | 2.6 nM | PMID16275086, PMID10509931 | BindingDB,ChEMBL |
Ki | 2.6 nM | PMID18821747, PMID19762245, PMID17516639, PMID20617791, PMID20560643, PMID21366266, PMID18266313, PMID23623418 | BindingDB,ChEMBL |
logEC50 | -9.0 - | PMID18266313 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417